GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Hydrocodone ER tablets - VANTRELA ER

Local RX List renal extractBase record retrieved 2026-09-07See the evidence for this drug2 sources available - open source summaries, references and comparisons

VANTRELA ER

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
The requested lower starting amount may not fit this ER product

The VANTRELA ER renal instructions specify a reduced starting amount and direct another analgesic when the required dose is below the available minimum strength.

Before applying: Do not split extended-release tablets to manufacture an unsupported strength or transfer another hydrocodone brand's instruction. Verify current product availability.

Also check: The requested lower starting amount may not fit this ER product

Rxlist source

GlobalRPh RX List - Vantrela ER

Product / population
VANTRELA ER only; not other hydrocodone release forms or combination analgesics.
Renal measure
Moderate/severe renal impairment and ESRD; product-specific starting-dose instructions.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

For moderate or severe impairment or ESRD, begin at one-half the recommended starting dose and titrate cautiously while watching for respiratory depression. Mild renal impairment does not require a starting-dose adjustment. If the needed dose is below the available 15 mg strength, consider an alternative analgesic rather than altering an extended-release tablet. These are starting-dose and monitoring instructions, not permission to halve every established regimen without clinical review.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-07. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/vantrela-er-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

GlobalRPh RX List

GlobalRPh RX List - VANTRELA ER

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Oral VANTRELA ER hydrocodone tablets; not all hydrocodone formulations

Renal method: Renal severity categories; source PK bands distinguish CrCl 30-50 and <30
Retrieved: 2026-09-07

Read local renal resultOpen original reference
GlobalRPh RX List

GlobalRPh RX List - Vantrela ER

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

VANTRELA ER only; not other hydrocodone release forms or combination analgesics.

Renal method: Moderate/severe renal impairment and ESRD; product-specific starting-dose instructions.
Retrieved: 2026-09-07

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

formulation strength limit

The requested lower starting amount may not fit this ER product

The VANTRELA ER renal instructions specify a reduced starting amount and direct another analgesic when the required dose is below the available minimum strength.

How to use this: Do not split extended-release tablets to manufacture an unsupported strength or transfer another hydrocodone brand's instruction. Verify current product availability.

GlobalRPh RX List - VANTRELA ER

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeGlobalRPh RX List - VANTRELA ERGlobalRPh RX List - Vantrela ER
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/vantrela-er-drug/

Exact product and population

Oral VANTRELA ER hydrocodone tablets; not all hydrocodone formulations

RDM38-SCOPE-hydrocodone-vantrela-er · Source section: Selected source product scopeRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - VANTRELA ER

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Oral VANTRELA ER hydrocodone tablets; not all hydrocodone formulations

Renal method: Renal severity categories; source PK bands distinguish CrCl 30-50 and <30
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

Mild renal impairment does not require a starting-dose adjustment in the selected source. For moderate or severe impairment, or ESRD, start at one-half the recommended initial dose, then titrate carefully while watching for sedation, respiratory depression and hypotension.

If the required initial dose would be less than 15 mg, use an alternative analgesic rather than creating an unsupported split extended-release dose. The pharmacokinetic discussion must not be used to override the explicit ESRD starting-dose instruction. Current availability and the exact product label still require verification.

RDM38-rxlist-hydrocodone-vantrela-er-419c6289d2-C1 · Source locator: Dosage in renal impairment; use in specific populations; PK

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/vantrela-er-drug/
Retrieved
2026-09-07
Renal-function method
Renal severity categories; source PK bands distinguish CrCl 30-50 and <30
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
00c4123eca9094a02e3ca6f3e83b44332c6143f3eddebac49bf34948d527b780
Rxlist

GlobalRPh RX List - Vantrela ER

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · VANTRELA ER only; not other hydrocodone release forms or combination analgesics.

Renal method: Moderate/severe renal impairment and ESRD; product-specific starting-dose instructions.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For moderate or severe impairment or ESRD, begin at one-half the recommended starting dose and titrate cautiously while watching for respiratory depression. Mild renal impairment does not require a starting-dose adjustment. If the needed dose is below the available 15 mg strength, consider an alternative analgesic rather than altering an extended-release tablet. These are starting-dose and monitoring instructions, not permission to halve every established regimen without clinical review.

RDM40-rxlist-hydrocodone-vantrela-er-419c6289d2-C1 · Source locator: Selected renal dosing, renal impairment, toxicity and pharmacokinetic subsections as identified in the summary.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/vantrela-er-drug/
Retrieved
2026-09-07
Renal-function method
Moderate/severe renal impairment and ESRD; product-specific starting-dose instructions.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
91c08363224df8a3ec67f6f7405182e122cf078cb4300a05e71e08a02a1b5e7b

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 2 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/vantrela-er-drug/
Source retrieval
2026-09-07. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
d9d7e450139643f7db90cc38b94a7c50d2f117bb4029ca40c0fe471d8d35c699
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report